Kilitch Drugs (India) (KILITCH)₹200.54+4.94%Pharmaceuticals
At the end of the Jun 2026 quarter, Kilitch Drugs (India)'s shareholders were: promoters 63.81%, FIIs 0.12%, public 36.07%. Promoter holding is unchanged on the quarter. FII holding is up 0.12 percentage points from 0.00% a year earlier. It had 12,629 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 69.27% | 69.27% | 69.27% | 69.27% | 69.27% | 69.27% | 69.27% | 69.27% | 63.81% | 63.81% | 63.81% | 63.81% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.12% |
| Public | 30.73% | 30.73% | 30.73% | 30.73% | 30.73% | 30.73% | 30.73% | 30.73% | 36.19% | 36.19% | 36.19% | 36.07% |
| Number of shareholders | 9,003 | 9,063 | 9,526 | 9,621 | 9,921 | 10,140 | 9,750 | 10,380 | 10,930 | 12,045 | 11,786 | 12,629 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Kilitch Company (Pharma) Limited | Promoter | 37.86% | 0.00 |
| Bhavin Mukund Mehta | Promoter | 14.46% | 0.00 |
| Mukund Mehta | Promoter | 6.55% | 0.00 |
| Mira Bhavin Mehta | Promoter | 4.82% | 0.00 |
| Dipak Kanayalal Shah | Public | 3.22% | −0.44 |
| Investor Education and Protection Fund Authority | Public | 2.30% | New |
| Mukul Mahavir Agrawal | Public | 1.33% | 0.00 |
| Premilaben Rameshchandra Shah | Public | 1.13% | 0.00 |
| Investor Education And Protection Fund Authority Ministry Of Corporate Affairs | Public | Exited | — |
Promoters held 63.81% of Kilitch Drugs (India) at the end of the Jun 2026 quarter, down 5.46 percentage points from 69.27% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.12% (up 0.12 percentage points from 0.00% a quarter earlier) and domestic institutions (DIIs) held no reported stake.
Kilitch Drugs (India) had 12,629 shareholders at the end of the Jun 2026 quarter, against 10,380 a year earlier.
Dipak Kanayalal Shah (Public) held 3.22% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.